ANTICLASTOGENIC EFFECTS OF 13-CIS-RETINOIC ACID INVITRO

被引:14
|
作者
TRIZNA, Z
HSU, TC
SCHANTZ, SP
LEE, JJ
HONG, WK
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CELL BIOL,BOX 181,1515 HOLCOMBE BLVD,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED ONCOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOMATH,HOUSTON,TX 77030
[4] NATL INST ONCOL,DEPT HEAD & NECK SURG,H-1122 BUDAPEST,HUNGARY
[5] MEM SLOAN KETTERING CANC CTR,DEPT HEAD & NECK SURG,NEW YORK,NY 10021
关键词
D O I
10.1016/0959-8049(93)90592-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The anticlastogenic effects of 13-cis-retinoic acid were studied in four human lymphoblastoid cell lines and in primary lymphocyte cultures derived from the peripheral blood of 11 study subjects. Cells were pre-incubated with 13-cis-retinoic acid in the concentration range of 10(-8)-10(-5) mol/l for 24 h and the numbers of chromatid breaks per cell induced by bleomycin were determined. The presence of 13-cis-retinoic acid decreased the number of breaks per cell by 13.0 to 59.5% in lymphoblastoid cell lines and by 0 to 57.4% in primary lymphocyte cultures (in the concentration ranges of 10(-8)-10(-6) mol/l and of 10(-8)-10(-5) mol/l, respectively). Regression analysis showed that there was a statistically significant correlation between the presence of 13-cis-retinoic acid and protection against bleomycin-induced clastogenicity. These data give additional information to the knowledge of possible chemopreventive mechanisms of action of 13-cis-retinoic acid.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 50 条